2010
DOI: 10.1097/prs.0b013e3181f446bc
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic Metabolic Inhibition: Hydrogen Sulfide Significantly Mitigates Skeletal Muscle Ischemia Reperfusion Injury In Vitro and In Vivo

Abstract: These findings confirm that the preischemic delivery of hydrogen sulfide limits ischemia-reperfusion injury-induced cellular damage in myotubes and skeletal muscle and suggests that, when given in the appropriate dose, this molecule may have significant therapeutic applications in multiple clinical scenarios.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
35
0

Year Published

2011
2011
2020
2020

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 34 publications
(35 citation statements)
references
References 28 publications
0
35
0
Order By: Relevance
“…It has been implicated that reactive oxygen species played a role in physiopathology of much diseases 63,64 . As a conclusion, the lipid peroxidation results in cellular injury, causing structural and functional alterations in the cells [65][66][67] . SOD, CAT and GPx are known as endogenous antioxidants, and the first-line defence mechanism against free radical damage 58-70 .…”
Section: Resultsmentioning
confidence: 99%
“…It has been implicated that reactive oxygen species played a role in physiopathology of much diseases 63,64 . As a conclusion, the lipid peroxidation results in cellular injury, causing structural and functional alterations in the cells [65][66][67] . SOD, CAT and GPx are known as endogenous antioxidants, and the first-line defence mechanism against free radical damage 58-70 .…”
Section: Resultsmentioning
confidence: 99%
“…It is also a cause of irreversible damage to skeletal muscle made ischemic either as the result of pathologic hypoperfusion or of a planned surgical intervention. On the basis of results of both in vitro and in vivo experiments, it was recently concluded that the preischemic or postischemic delivery of NaHS limits I/R-induced cellular damage and confers significant long-term protection, that intravenous or even intra-arterial delivery of an H 2 S donor would provide more focused treatment of target tissue and, when administered in appropriate doses and within the proper time frame, H 2 S holds significant promise as a cytoprotective agent (65).…”
Section: Cytoprotection and Pharmacological Conditioningmentioning
confidence: 99%
“…protection from ischemia/reperfusion injury has been demonstrated in a number of extracardiac organs, including the kidney (171), which presumably offsets the reduction in endogenous H 2 S production (192), liver and small intestine (52,198), skeletal muscle (49,51), and cellular components of cutaneous tissue (50). As in the vasculature, H 2 S has been proposed to combine with NO to produce a nitrosothiol with inotropic properties (195,194).…”
Section: R301 Therapeutic Potential Of H2smentioning
confidence: 99%